Mind-altering substances could be on the cusp of medical acceptability, with sovereign wealth funds Temasek and Mubadala in talks to fund biotech groups harnessing their potential
Food and Drug Administration
Shannon group Biomimetic Innovations has developed glue to accelerate healing for patients after fractures
Priothera looking to improve survival rates of patients with acute myeloid leukaemia
Treatment offers relief and possibly a cure for patients with sickle cell disease and one other blood ailment
Icon has developed Cassandra AI which predicts likely post-marketing requirements
Medical device giant waiting for hoped-for approval from FDA for new procedure that was partly developed in Ireland
Former CEO is said to be among parties to signal interest in investing in embattled company, which is running out of cash just as it cracks US market
Dutch health technology group makes provision for resolution of a class-action lawsuit
Drugs giant says application with the FDA had become overly complicated and ‘very large’
Holohan to discuss objections to antigen testing before Oireachtas committee
Placing of shares comes ahead of submission to regulators for approval of drug for rare condition
Irish-founded company also expects the product will be on sale in EU shortly
Company is also working on a second test to detect antibodies in just 12 minutes
Stock advances over fivefold in 12 months on evidence of medicine’s cardiovascular effect
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices